Cargando…
Mifepristone Promotes Adiponectin Production and Improves Insulin Sensitivity in a Mouse Model of Diet-Induced-Obesity
The steroid receptor antagonist mifepristone is used as an anti-cancer agent, eliciting both cytostatic and cytotoxic effects on malignant cells. However, the metabolic effects of long-term treatment with mifepristone have remained unclear. The effects of mifepristone on insulin sensitivity and adip...
Autores principales: | Hashimoto, Takeshi, Igarashi, Junsuke, Hasan, Arif U., Ohmori, Koji, Kohno, Masakazu, Nagai, Yukiko, Yamashita, Tetsuo, Kosaka, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819252/ https://www.ncbi.nlm.nih.gov/pubmed/24223187 http://dx.doi.org/10.1371/journal.pone.0079724 |
Ejemplares similares
-
Involvement of S1P(1) receptor pathway in angiogenic effects of a novel adenosine-like nucleic acid analog COA-Cl in cultured human vascular endothelial cells
por: Igarashi, Junsuke, et al.
Publicado: (2014) -
Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023) -
Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects
por: Wallia, Amisha, et al.
Publicado: (2013) -
Hydrodynamic Delivery of Adiponectin and Adiponectin Receptor 2 Gene Blocks High-Fat Diet-Induced Obesity and Insulin Resistance
por: Ma, Yongjie, et al.
Publicado: (2013) -
Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)